Photoacoustic Imaging in Oncology: Translational Preclinical and Early Clinical Experience

被引:150
|
作者
Valluru, Keerthi S. [1 ]
Wilson, Katheryne E. [1 ]
Willmann, Jurgen K. [1 ]
机构
[1] Stanford Univ, Sch Med, Mol Imaging Program Stanford, Dept Radiol, 300 Pasteur Dr,Room H1307, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
BREAST-CANCER; SCREENING MAMMOGRAPHY; SKIN-CANCER; REAL-TIME; PROSTATE; ULTRASOUND; BRACHYTHERAPY; TOMOGRAPHY; DIAGNOSIS; NANOPARTICLES;
D O I
10.1148/radiol.16151414
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Photoacoustic imaging has evolved into a clinically translatable platform with the potential to complement existing imaging techniques for the management of cancer, including detection, characterization, prognosis, and treatment monitoring. In photoacoustic imaging, tissue is optically excited to produce ultrasonographic images that represent a spatial map of optical absorption of endogenous constituents such as hemoglobin, fat, melanin, and water or exogenous contrast agents such as dyes and nanoparticles. It can therefore provide functional and molecular information that allows noninvasive soft-tissue characterization. Photoacoustic imaging has matured over the years and is currently being translated into the clinic with various clinical studies underway. In this review, the current state of photoacoustic imaging is presented, including techniques and instrumentation, followed by a discussion of potential clinical applications of this technique for the detection and management of cancer.
引用
收藏
页码:332 / 349
页数:18
相关论文
共 50 条
  • [41] Challenging the status quo to improve the translational potential of preclinical oncology studies
    Connor, Kate
    Golebiewska, Anna
    Byrne, Annette T.
    NATURE REVIEWS CANCER, 2025, 25 (01) : 3 - 4
  • [42] Antisense therapy in clinical oncology - Preclinical and clinical experiences
    Tamm, Ingo
    Wagner, Mandy
    MOLECULAR BIOTECHNOLOGY, 2006, 33 (03) : 221 - 238
  • [43] Preclinical glioma models in neuro-oncology: enhancing translational research
    Barachini, Serena
    Morelli, Mariangela
    Santo Santonocito, Orazio
    Mazzanti, Chiara Maria
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (06) : 536 - 542
  • [44] Models in Translational Oncology: A Public Resource Database for Preclinical Cancer Research
    Galuschka, Claudia
    Proynova, Rumyana
    Roth, Benjamin
    Augustin, Hellmut G.
    Mueller-Decker, Karin
    CANCER RESEARCH, 2017, 77 (10) : 2557 - 2563
  • [45] Imaging preclinical tumour models: improving translational power
    de Jong, Marion
    Essers, Jeroen
    van Weerden, Wytske M.
    NATURE REVIEWS CANCER, 2014, 14 (07) : 481 - 493
  • [46] Early Exposure to a Clinical Oncology Course During the Preclinical Second Year of Medical School
    Granek, Leeat
    Lazarev, Irena
    Birenstock-Cohen, Shira
    Geffen, David B.
    Riesenberg, Klaris
    Ariad, Samuel
    ACADEMIC MEDICINE, 2015, 90 (04) : 454 - 457
  • [47] Polo-Like Kinase (PLK) Inhibitors in Preclinical and Early Clinical Development in Oncology
    Schoffski, Patrick
    ONCOLOGIST, 2009, 14 (06): : 559 - 570
  • [48] Imaging preclinical tumour models: improving translational power
    Marion de Jong
    Jeroen Essers
    Wytske M. van Weerden
    Nature Reviews Cancer, 2014, 14 : 481 - 493
  • [49] Preclinical imaging and translational animal models of cancer for accelerated clinical implementation of nanotechnologies and macromolecular agents
    De Souza, Raquel
    Spence, Tara
    Huang, Huang
    Allen, Christine
    JOURNAL OF CONTROLLED RELEASE, 2015, 219 : 313 - 330
  • [50] Preclinical evaluation of a novel cyanine dye for tumor imaging with in vivo photoacoustic imaging
    Temma, Takashi
    Onoe, Satoru
    Kanazaki, Kengo
    Ono, Masahiro
    Saji, Hideo
    JOURNAL OF BIOMEDICAL OPTICS, 2014, 19 (09)